<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="653">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>18/10/2005</approvaldate>
  <actrnumber>ACTRN12605000653662</actrnumber>
  <trial_identification>
    <studytitle>Maxillary Three-Implant Overdentures: An Alternative Prosthodontic Treatment Concept with Opposing Mandibular Two-Implant Overdentures.</studytitle>
    <scientifictitle>Complete Tooth Loss:A Randomized Controlled Clincial Trial with Maxillary Three-Implant Overdentures Opposing Mandibular Two-Implant Overdentures.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total tooth loss - edentulism</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Placement of oral implants in the upper jaw and implant overdentures, when opposing lower jaw 2-implant overdentures.</interventions>
    <comparator>Conventional complete maxillary dentures opposing mandibular 2-implant overdentures</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To determine implant success of maxillary three-implant overdentures using splinted and unsplinted prosthodontic designs on narrow diameter roughened surface implants (with a one-stage surgical procedure and a 12-week healing period), when opposing mandibular two-implant overdentures.</outcome>
      <timepoint>52 weeks post procedure and 10 years post procedure</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To determine prosthodontic success of maxillary three-implant overdentures using splinted and unsplinted prosthodontic designs on narrow diameter roughened surface implants (with a one-stage surgical procedure and a 12-week healing period), when opposing mandibular two-implant overdentures.</outcome>
      <timepoint> 10 years post procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>An edentulous maxilla, and had been successfully wearing their mandibular two-implant overdenture for at least three years. </inclusivecriteria>
    <inclusiveminage>55</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Those with Lekholm &amp; Zarb classification16 Type E maxillae (determined radiologically), a history of smoking, a systemic disease likely to compromise implant surgery, previously bone-grafted jaws, or a history of bruxism.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes</concealment>
    <sequence>Coin Toss and Blocking</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>2/11/2001</anticipatedstartdate>
    <actualstartdate>12/11/2001</actualstartdate>
    <anticipatedenddate />
    <actualenddate>15/12/2002</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>NobelBiocare Pty Ltd Australia, </primarysponsorname>
    <primarysponsoraddress>4/7 Eden Park Drive, Sydney NSW 2113, Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>NobelBiocare</fundingname>
      <fundingaddress>4/7 Eden Park Drive, Sydney NSW 2113, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Southern Implants</fundingname>
      <fundingaddress>1 Albert Rd, Pretoria, 0062, South Africa
PO Box 605, Irene, 0062, South Africa</fundingaddress>
      <fundingcountry>South Africa</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Southern Implants, South Africa</sponsorname>
      <sponsoraddress>1 Albert Rd, Pretoria, 0062, South Africa
PO Box 605, Irene, 0062, South Africa</sponsoraddress>
      <sponsorcountry>South Africa</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the implant success and prosthetic maintenance of 3 upper jaw implants supporting an overdenture in patients with a lower jaw 2-implant overdenture over a 10-year period.

</summary>
    <trialwebsite />
    <publication>Al-Zubeidi M., Alsabeeha N, Thomson WM, Payne AGT. (2012) Patient outcomes with maxillary 3-implant overdentures opposing mandibular 2-implant overdentures. Clin Implant Dent Relat Res  2012;14,(suppl)1:e11-19.

Ma S, Tawse-Smith A, De Silva RK, Atieh MA, Alsabeeha NHM, Payne AGT. Maxillary 3-implant overdentures opposing mandibular 2-implant overdentures: 10-year surgical outcomes of a randomized controlled trial. Clin Implant Dent Relat Res 2015 doi: 10.1111/cid.12325.

Ma S, Waddell JN, Atieh MA, Alsabeeha NHM, Payne AGT. Maxillary 3-implant overdentures opposing mandibular 2-implant overdentures: 10-year prosthodontic outcomes of a randomized controlled trial. Int J Prosthodontics- submitted for publication</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>New Zealand - Lower South Island Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>1/10/2001</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Alan GT Payne</name>
      <address>Gentle Dental Co - Gus Cameron
17 Rust Avenue
Whangarei
0110
Northland</address>
      <phone>+64 9 4300046</phone>
      <fax>+64 3 4795079</fax>
      <email>payne@actrix.gen.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sunyoung Ma</name>
      <address>Oral Implantology Area of Research Strength
School of Dentistry
University of Otago
280 Great King St
Dunedin 9003</address>
      <phone>+ 64 3 4797044</phone>
      <fax>+64 3 4795079</fax>
      <email>sunyoung.ma@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alan GT Payne</name>
      <address>Gentle Dental Co - Gus Cameron
17 Rust Avenue
Whangarei
Northland</address>
      <phone>+6494300046</phone>
      <fax>+64 9 4302807</fax>
      <email>payne@actrix.gen.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alan GT Payne</name>
      <address>Gentle Dental Co - Gus Cameron
17 Rust Avenue
Whangarei
0110
Northland</address>
      <phone>+6494300046</phone>
      <fax>+6494302807</fax>
      <email>payne@actrix.gen.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>